Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - NASDAQ:CROX - US2270461096 - Common Stock

76.7 USD
-3.69 (-4.59%)
Last: 10/10/2025, 9:19:09 PM
76.62 USD
-0.08 (-0.1%)
After Hours: 10/10/2025, 9:19:09 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CROX. CROX was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CROX is valued quite cheap, while showing a decent growth score. This is a good combination! This makes CROX very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
In the past year CROX had a positive cash flow from operations.
CROX had positive earnings in each of the past 5 years.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

With a decent Return On Assets value of 5.31%, CROX is doing good in the industry, outperforming 68.75% of the companies in the same industry.
CROX has a Return On Equity of 16.64%. This is in the better half of the industry: CROX outperforms 72.92% of its industry peers.
CROX has a Return On Invested Capital of 24.29%. This is amongst the best in the industry. CROX outperforms 93.75% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 12.15%.
The 3 year average ROIC (22.59%) for CROX is below the current ROIC(24.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROIC 24.29%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX's Profit Margin of 5.72% is fine compared to the rest of the industry. CROX outperforms 75.00% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX's Operating Margin of 24.24% is amongst the best of the industry. CROX outperforms 97.92% of its industry peers.
CROX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 59.36%, CROX is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CROX has less shares outstanding
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.66 indicates that CROX is not in any danger for bankruptcy at the moment.
CROX has a better Altman-Z score (3.66) than 68.75% of its industry peers.
The Debt to FCF ratio of CROX is 1.79, which is an excellent value as it means it would take CROX, only 1.79 years of fcf income to pay off all of its debts.
CROX has a Debt to FCF ratio of 1.79. This is amongst the best in the industry. CROX outperforms 85.42% of its industry peers.
CROX has a Debt/Equity ratio of 0.97. This is a neutral value indicating CROX is somewhat dependend on debt financing.
CROX's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. CROX is outperformed by 70.83% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Altman-Z 3.66
ROIC/WACC2.34
WACC10.38%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.54 indicates that CROX should not have too much problems paying its short term obligations.
The Current ratio of CROX (1.54) is worse than 66.67% of its industry peers.
CROX has a Quick Ratio of 1.54. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.97, CROX perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.81% over the past year.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
Looking at the last year, CROX shows a small growth in Revenue. The Revenue has grown by 2.04% in the last year.
Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 27.23% on average per year.
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%

3.2 Future

Based on estimates for the next years, CROX will show a small growth in Earnings Per Share. The EPS will grow by 2.84% on average per year.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.29% yearly.
EPS Next Y-11.5%
EPS Next 2Y-6.5%
EPS Next 3Y-4.4%
EPS Next 5Y2.84%
Revenue Next Year-2.41%
Revenue Next 2Y-0.83%
Revenue Next 3Y-0.08%
Revenue Next 5Y2.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.75, which indicates a rather cheap valuation of CROX.
Compared to the rest of the industry, the Price/Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 95.83% of the companies listed in the same industry.
CROX is valuated cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
CROX is valuated cheaply with a Price/Forward Earnings ratio of 6.67.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CROX indicates a rather cheap valuation: CROX is cheaper than 97.92% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CROX to the average of the S&P500 Index (22.57), we can say CROX is valued rather cheaply.
Industry RankSector Rank
PE 5.75
Fwd PE 6.67
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CROX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CROX is cheaper than 89.58% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.45
EV/EBITDA 5.17
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of CROX may justify a higher PE ratio.
A cheap valuation may be justified as CROX's earnings are expected to decrease with -4.40% in the coming years.
PEG (NY)N/A
PEG (5Y)0.11
EPS Next 2Y-6.5%
EPS Next 3Y-4.4%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (10/10/2025, 9:19:09 PM)

After market: 76.62 -0.08 (-0.1%)

76.7

-3.69 (-4.59%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-30 2025-10-30/amc
Inst Owners103.9%
Inst Owner Change0%
Ins Owners2.6%
Ins Owner Change1.55%
Market Cap4.19B
Analysts74.55
Price Target89.62 (16.84%)
Short Float %12.48%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.97%
Min EPS beat(2)3.5%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)11.28%
Min EPS beat(4)3.5%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)12.22%
EPS beat(12)12
Avg EPS beat(12)13.45%
EPS beat(16)16
Avg EPS beat(16)15.25%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.03%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.22%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)6
Avg Revenue beat(12)0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)-7.19%
PT rev (3m)-30.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.41%
EPS NY rev (1m)-3.5%
EPS NY rev (3m)-9.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.72%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-4.05%
Valuation
Industry RankSector Rank
PE 5.75
Fwd PE 6.67
P/S 1.01
P/FCF 5.45
P/OCF 5
P/B 2.95
P/tB N/A
EV/EBITDA 5.17
EPS(TTM)13.35
EY17.41%
EPS(NY)11.5
Fwd EY14.99%
FCF(TTM)14.08
FCFY18.35%
OCF(TTM)15.33
OCFY19.99%
SpS75.77
BVpS26.02
TBVpS-5.84
PEG (NY)N/A
PEG (5Y)0.11
Profitability
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROCE 26.86%
ROIC 24.29%
ROICexc 25.67%
ROICexgc 50.56%
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
FCFM 18.58%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Debt/EBITDA 1.28
Cap/Depr 92.37%
Cap/Sales 1.65%
Interest Coverage 11.92
Cash Conversion 77.72%
Profit Quality 325.08%
Current Ratio 1.54
Quick Ratio 0.97
Altman-Z 3.66
F-Score8
WACC10.38%
ROIC/WACC2.34
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
EPS Next Y-11.5%
EPS Next 2Y-6.5%
EPS Next 3Y-4.4%
EPS Next 5Y2.84%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%
Revenue Next Year-2.41%
Revenue Next 2Y-0.83%
Revenue Next 3Y-0.08%
Revenue Next 5Y2.29%
EBIT growth 1Y-6.14%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-9.8%
EBIT Next 3Y-6.47%
EBIT Next 5Y3.43%
FCF growth 1Y3.44%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-1.37%
OCF growth 3Y20.5%
OCF growth 5Y61.62%